title: Effects of PI3Kgamma inhibition using AS-605240 in acute myocardial infarction.
authors.forename: Ignacio M
authors.initials: IM
authors.lastname: Seropian
authors.forename: Stefano
authors.initials: S
authors.lastname: Toldo
authors.forename: Antonio
authors.initials: A
authors.lastname: Abbate
authors.forename: Eleonora
authors.initials: E
authors.lastname: Mezzaroma
authors.forename: Benjamin W
authors.initials: BW
authors.lastname: Van Tassell
mesh_terms: D000818:Animals; D002317:Cardiovascular Agents / Q000494:pharmacology*; D004195:Disease Models, Animal; D005838:Genotype; D051379:Mice; D018345:Mice, Knockout; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D009206:Myocardium / Q000201:enzymology*; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010641:Phenotype; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011810:Quinoxalines / Q000494:pharmacology*; D045162:Thiazolidinediones / Q000494:pharmacology*; D016277:Ventricular Function, Left / Q000187:drug effects; D020257:Ventricular Remodeling / Q000187:drug effects
chemical_list: D002317:Cardiovascular Agents; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; D011810:Quinoxalines; D045162:Thiazolidinediones; C505144:5-quinoxalin-6-ylmethylenethiazolidine-2,4-dione